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Abstract
Cancer patients face many obstacles and challenges after being diagnosed with cancer.
Thomas Jefferson University Hospitals’ Sidney Kimmel Cancer Center (SKCC) has
effectively eliminated transportation as a barrier to care for patients receiving cancer
treatments such as chemotherapy and radiation. SKCC dedicates a full-time patient
navigator to assess and connect patients with appropriate transportation resources
based on location, insurance coverage, and mobility. The utilization of patient-focused
transportation platforms, such as Uber Health, RoundTrip, and Ride Health have
streamlined the process, while SKCC philanthropic funds have assisted with associated
financial costs. As a result of these resources, oncology patients who would have
ordinarily missed appointments due to lack of transportation are now more independent
and compliant with cancer treatment
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Method
The American Cancer Society (ACS) and the NCI-designated Sidney Kimmel Cancer
Center (SKCC) at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania
have focused efforts on increasing patient access to care. A full-time ACS patient
navigator connects patients with appropriate resources including ACS volunteer drivers
and Lyft transportation grant, medical assistance transportation programs, communitybased shared rides services for seniors and persons with disabilities, and private car
services. SKCC has also collaborated with technology-based companies including Uber
Health, RoundTrip, and Ride Health to ensure that all patients have access to
transportation in order to be fully compliant with treatment regimens. In 2017, the
Barbara A. Colameco’s Cancer Transportation Fund awarded SKCC a $52,000
philanthropic donation to completely eliminate the transportation disparity and
promote access for all oncology patients.
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Introduction
Transportation has been identified as a significant barrier for patients needing cancer
treatment such as chemotherapy or radiation. Access to transportation resources is
especially challenging for individuals traveling far distances for treatments that require
repeat visits (Guidry, Aday, Zhang & Winn, 1997). Furthermore, elderly, racial and
ethnic minorities, as well as patients with lower socioeconomic status and less social
support have increased transportation needs (Zullig et al., 2012). As a result, patients
with limited resources are often forced to pursue treatment centers based on geographic
proximity and accessibility, regardless of the quality and effectiveness of care (Finlayson,
Birkmeyer, Tosteson & Nease, 1999).
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Results

Conclusion

SKCC at Jefferson, a large urban health system, provides care to a diverse patient
population including a large number of underserved and underinsured individuals.
Philadelphia represents a diverse population: 42% African American, 13% Hispanic or
Latino, and almost 7% non-Hispanic Asian (US Census Bureau, 2010). Many patients
experience financial toxicity stemming from treatment-related costs where the annual
patient household income is $16,500.

Through the utilization of patient-focused transportation platforms, oncology patients
are more compliant with treatment regimens. Patients with a variety of physical
limitations can also connect with wheelchair vans and stretcher support vehicles to get to
and from appointments. Patients are empowered to act autonomously through:

Graphic 2: Transportation Impact
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The ACS patient navigator is able to track rides in real-time and receive regular reports
on ride usage. With support from philanthropy, the institution no longer has to bear the
cost of the transportation burden.

Practice Implications
With an increasingly competitive market for technology-based platforms, institutions
are looking for more cost-effective options to decrease missed appointments and
ultimately increase patient compliance. Having one less stressor in the cancer journey is
a powerful reliever of anxiety and worry for patients and families who are already
overwhelmed and stretched so thinly.
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